---
figid: PMC5857409__nihms910084f4
figlink: /pmc/articles/PMC5857409/figure/F4/
number: F4
caption: 'Proposed potential therapeutic targets in Erythroleukemia. A wide range
  of signaling pathway mutations (JAK2, NTRK1, ALK), epigenetic alterations (Hypomethylating
  agents, LSD-1 inhibitors, bromodomain inhibitors), and microRNA dysregulation (microRNA
  therapies) present with multiple options for therapeutic targeting. Abbreviations
  used: BRD-bromodomain reading proteins, miR-microRNA, EpoR-Erythropoietin receptor'
pmcid: PMC5857409
papertitle: Erythroleukemia-Historical perspectives and recent advances in diagnosis
  and management.
reftext: Prajwal Boddu, et al. Blood Rev. ;32(2):96-105.
pmc_ranked_result_index: '79832'
pathway_score: 0.8664256
filename: nihms910084f4.jpg
figtitle: Proposed potential therapeutic targets in Erythroleukemia
year: ''
organisms:
- Homo sapiens
ndex: 3a8f6443-df1e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5857409__nihms910084f4.html
  '@type': Dataset
  description: 'Proposed potential therapeutic targets in Erythroleukemia. A wide
    range of signaling pathway mutations (JAK2, NTRK1, ALK), epigenetic alterations
    (Hypomethylating agents, LSD-1 inhibitors, bromodomain inhibitors), and microRNA
    dysregulation (microRNA therapies) present with multiple options for therapeutic
    targeting. Abbreviations used: BRD-bromodomain reading proteins, miR-microRNA,
    EpoR-Erythropoietin receptor'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GATA5
  - CHP2
  - MAP2K2
  - EPOR
  - MAP2K1
  - JAK2
  - BRAF
  - ALK
  - TECR
  - ARAF
  - RAF1
  - JAK1
  - JAK3
  - TYK2
  - Cancer
genes:
- word: GATAS
  symbol: GATAS
  source: hgnc_alias_symbol
  hgnc_symbol: GATA5
  entrez: '140628'
- word: CHP2
  symbol: CHP2
  source: hgnc_symbol
  hgnc_symbol: CHP2
  entrez: '63928'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: EpoR
  symbol: EPOR
  source: hgnc_symbol
  hgnc_symbol: EPOR
  entrez: '2057'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ALK
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: ters
  symbol: TER
  source: hgnc_alias_symbol
  hgnc_symbol: TECR
  entrez: '9524'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5857409__F4
redirect_from: /figures/PMC5857409__F4
figtype: Figure
---
